News & Updates
Inside Innovation
The latest news and advances from the world's most exciting life science cluster.
Seattle biotech firm Umoja Biopharma raises $53M as it tackles unique approach to immunotherapy
Umoja Biopharma, a startup founded last year by Seattle biotech veteran Andy Scharenberg, announced that it has raised $53 million in a recent Series A
Seattle Children’s Therapeutics leverages biotech innovation in quest for new treatments for kids
Seattle Children’s Hospital, consistently ranked as one of the best children’s hospitals in the U.S., has launched a new endeavor: Seattle Children’s Therapeutics. This research institution
BMS earmarks $100M of its $300M equity pledge for diverse clinical trial investigators
Following its August 2020 pledge to allocate $300 million over the next five years to diversity initiatives, Bristol Myers Squibb announced that $100 million of that
New Type of Test May Better Discern Immunity to the Coronavirus
Seattle-based Adaptive Biotechnologies has developed a new type of COVID-19 test that uses a blood sample to determine immune response to the virus. The test
Synthetic biology startup AbSci raises $65M to expand ‘Protein Printing’ tech
Vancouver, Wash.-based biotech company AbSci raised an additional $65 million to help grow its synthetic biology platform. The company’s “Protein Printing” technology is used to
Seattle named a top life science hub by CBRE
CBRE named Seattle’s life science industry one of the top in the nation, according to a recent report. Ranked ninth, Seattle brought in record venture